Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3232 Treatment outcomes of patients with G3 neuroendocrine neoplasms - Data from the German NET Registry

Introduction: NEN G3 comprise a heterogeneous group of rare aggressive neoplasm with few established treatment options.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Luecke S

Authors: Luecke S, Fottner C, Lahner H, Jann H, Zolnowski D,

Keywords: NEN G3, NEC, NET, Ki67, prognosis, chemotherapy,

#2793 A Phase II, Open-Label, Multicenter Trial of Avelumab in Patients with Advanced, Metastatic High Grade Neuroendocrine Carcinomas NEC G3 (WHO 2010) Progressive after First-line Chemotherapy (AVENEC)

Introduction: High grade Neuroendocrine Neoplasias (NEN) are rare tumors with a poor prognosis and no established second line therapy.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Weber M

Authors: Fottner C, Apostolidis L, Ferrata M, Krug S, Michl P,

Keywords: NEC, NEN G3, check-point inhibitor, Avelumab, anti-PD-L1-antibody, immunotherapy,

#2737 Identification of a Novel MAFA Missense Mutation Causing Familial Insulinomatosis

Introduction: Insulinomatosis is a rare pancreatic disease characterized by an adult-onset condition of recurrent hyperinsulinemic hypoglycemia caused by multiple insulin-secreting neuroendocrine tumors.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Fottner C

Authors: Fottner C, Sollfrank S, Ghiasi M, Ferrata M, Schad A,

Keywords: Insulinomatosis, Insulinoma, hyperinsulinemic hypoglycemia, MAFA,

#1335 Quality of Life (QoL) and Psycho-social Distress in Patients with Neuroendocrine Neoplasias (NEN) – Correlation with Tumor Stage, Clinical Status and Treatment

Introduction: Pat. with NEN require long-term therapy potentially associated with an impairment of QoL

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Fottner C

Authors: Reinhold M, Beutel M, Weber M,

Keywords: Psychooncology, Quality of Life,

#1201 Results of Sunitinib Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Outcome Data from the German NET-Register

Introduction: Among modern treatments (Tx) for neuroendocrine neoplasms (NEN) sunitinib (SUN) has impacted Tx of primarily pancreatic NEN (pNEN).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Bacher M, Maasberg S, Fottner C, Begum N, Quietzsch D,

Keywords: sunitinib, outcome,